Targeted gene addition to human mesenchymal stromal cells as a cell-based plasma-soluble protein delivery platform

References

• Vallee M, Cote JF, Fradette J. Adipose-tissue engineering: taking advantage of the properties of human adipose-derived stem/stromal cells. Pathol Biol (Paris). 2009;57:309–17.
   PubMed Web of Science ®Google Scholar
• Prockop DJ, Sekiya I, Colter DC. Isolation and characterization of rapidly self-renewing stem cells from cultures of human marrow stromal cells. Cytotherapy. 2001;3:393–6.
   PubMed Web of Science ®Google Scholar
• Sueblinvong V, Loi R, Eisenhauer PL, Bernstein IM, Suratt BT, Spees JL, . Derivation of lung epithelium from human cord blood-derived mesenchymal stem cells. Am J Respir Crit Care Med. 2008;177:701–11.
   PubMed Web of Science ®Google Scholar
• Trottier V, Marceau-Fortier G, Germain L, Vincent C, Fradette J. IFATS collection: using human adipose-derived stem/stromal cells for the production of new skin substitutes. Stem Cells. 2008;26:2713–23.
   PubMed Web of Science ®Google Scholar
• Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, . Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7:211–28.
   PubMedGoogle Scholar
• Schilling T, Noth U, Klein-Hitpass L, Jakob F, Schutze N. Plasticity in adipogenesis and osteogenesis of human mesenchymal stem cells. Mol Cell Endocrinol. 2007;271:1–17.
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Ringden O. Mesenchymal stem cells: properties and role in clinical bone marrow transplantation. Curr Opin Immunol. 2006;18:586–91.
   PubMed Web of Science ®Google Scholar
• Eliopoulos N, Lejeune L, Martineau D, Galipeau J. Human-compatible collagen matrix for prolonged and reversible systemic delivery of erythropoietin in mice from gene-modified marrow stromal cells. Mol Ther. 2004;10:741–8.
   PubMed Web of Science ®Google Scholar
• Karnieli O, Izhar-Prato Y, Bulvik S, Efrat S. Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation. Stem Cells. 2007; 25:2837–44.
   PubMed Web of Science ®Google Scholar
• Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P, . LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science. 2003;302:415–9.
   PubMed Web of Science ®Google Scholar
• Howe SJ, Mansour MR, Schwarzwaelder K, Bartholomae C, Hubank M, Kempski H, . Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J Clin Invest. 2008;118:3143–50.
   PubMed Web of Science ®Google Scholar
• Lombardo A, Genovese P, Beausejour CM, Colleoni S, Lee YL, Kim KA, . Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat Biotechnol. 2007;25:1298–306.
   PubMed Web of Science ®Google Scholar
• Moehle EA, Rock JM, Lee YL, Jouvenot Y, DeKelver RC, Gregory PD, . Targeted gene addition into a specified location in the human genome using designed zinc finger nucleases. Proc Natl Acad Sci USA. 2007;104:3055–60.
   PubMed Web of Science ®Google Scholar
• Urnov FD, Miller JC, Lee YL, Beausejour CM, Rock JM, Augustus S, . Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature. 2005; 435:646–51.
   PubMed Web of Science ®Google Scholar
• Perez EE, Wang J, Miller JC, Jouvenot Y, Kim KA, Liu O, . Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nat Biotechnol. 2008;26:808–16.
   PubMed Web of Science ®Google Scholar
• Porteus MH. Mammalian gene targeting with designed zinc finger nucleases. Mol Ther. 2006;13:438–46.
   PubMed Web of Science ®Google Scholar
• Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, . Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature. 1996;382:722–5.
   PubMed Web of Science ®Google Scholar
• Yanez-Munoz RJ, Balaggan KS, MacNeil A, Howe SJ, Schmidt M, Smith AJ, . Effective gene therapy with nonintegrating lentiviral vectors. Nat Med. 2006;12:348–53.
   PubMed Web of Science ®Google Scholar
• Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, . In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 1996;272:263–7.
   PubMed Web of Science ®Google Scholar
• Szymczak AL, Workman CJ, Wang Y, Vignali KM, Dilioglou S, Vanin EF, . Correction of multi-gene deficiency in vivo using a single ‘self-cleaving’ 2A peptide-based retroviral vector. Nat Biotechnol. 2004;22:589–94.
   PubMed Web of Science ®Google Scholar
• Campeau PM, Rafei M, Francois M, Birman E, Forner KA, Galipeau J. Mesenchymal stromal cells engineered to express erythropoietin induce anti-erythropoietin antibodies and anemia in allorecipients. Mol Ther. 2009;17:369–72.
   Web of Science ®Google Scholar